Advertisement
News
Advertisement

FDA to Review Bausch + Lomb's Intraocular Lens

Wed, 02/27/2013 - 1:42pm
Mass Device

Bausch + Lomb lands a panel date with the FDA to review its Trulign Toric vision-correcting implant.

Bausch + Lomb logo

Eye care giant Bausch + Lomb won a date with the FDA for review of its Trulign Toric intraocular lens for improving vision in patient who have undergone cataract surgery.

On April 8, 2013, the FDA's Ophthalmic Devices Panel will review clinical data and cast a vote on the Trulign Toric implant in treatment of patients with vision impairment as a result of aphakia and postoperative refractive astigmatism.

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading